期刊
OCULAR IMMUNOLOGY AND INFLAMMATION
卷 30, 期 7-8, 页码 1599-1603出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/09273948.2021.1919310
关键词
Immune reconstitution inflammatory syndrome; anti-retroviral therapy; uveitis; HIV; immunosuppressant
A retrospective review of HIV patients with noninfectious uveitis found that uveitis could be the initial manifestation of immune-mediated disorders in patients with well-controlled HIV infection, and immunosuppression appeared to be a safe therapeutic option.
Objective: To describe a retrospective review of HIV patients with noninfectious uveitis. Data collected included: demographics, anatomic classification and phenotypic diagnosis of the uveitis, systemic immune-mediated disorders (IMD), time from HIV diagnosis to uveitis, CD4 count, viral load, treatment and complications of treatment and time of follow-up. Results: Twenty patients (18 males) were included. The time lag between HIV diagnosis and the onset of uveitis was 9 +/- 8.5 years. Mean CD4 count was 670 +/- 294 cells/ml. Viral load was undetectable in 14 out of 18 cases. In 6 patients IMD was diagnosed prior to or concurring with the uveitis diagnosis. The use of immunosuppressive therapies was necessary in 6 patients (including biologics in 4 cases). The mean follow-up was 42.2 months. Conclusions: noninfectious uveitis could be the first manifestation of IMD in patients with well-controlled HIV infection. Immunosuppression appeared to be a safe therapeutic option in our cohort of patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据